Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125704303 | 12570430 | 3 | F | 2014 | 20160831 | 20160719 | 20160912 | PER | US-CELGENEUS-USA-2016073305 | CELGENE | 70.52 | YR | F | Y | 0.00000 | 20160912 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125704303 | 12570430 | 1 | PS | REVLIMID | LENALIDOMIDE | 1 | Oral | U | UNKNOWN | 21880 | 25 | MG | CAPSULES | QD | |||||
| 125704303 | 12570430 | 2 | SS | REVLIMID | LENALIDOMIDE | 1 | Oral | U | UNKNOWN | 21880 | 15 | MG | CAPSULES | QD | |||||
| 125704303 | 12570430 | 3 | SS | REVLIMID | LENALIDOMIDE | 1 | Oral | U | UNKNOWN | 21880 | 10 | MG | CAPSULES | QD | |||||
| 125704303 | 12570430 | 4 | SS | REVLIMID | LENALIDOMIDE | 1 | Oral | U | UNKNOWN | 21880 | 15 | MG | CAPSULES | QD | |||||
| 125704303 | 12570430 | 5 | SS | REVLIMID | LENALIDOMIDE | 1 | Oral | U | UNKNOWN | 21880 | 10 | MG | CAPSULES | QD | |||||
| 125704303 | 12570430 | 6 | SS | REVLIMID | LENALIDOMIDE | 1 | Oral | U | UNKNOWN | 21880 | 10 | MG | CAPSULES | QD | |||||
| 125704303 | 12570430 | 7 | SS | REVLIMID | LENALIDOMIDE | 1 | Oral | 5- 10 MG | U | UNKNOWN | 21880 | CAPSULES | QD | ||||||
| 125704303 | 12570430 | 8 | SS | REVLIMID | LENALIDOMIDE | 1 | Oral | U | UNKNOWN | 21880 | 5 | MG | CAPSULES | QD | |||||
| 125704303 | 12570430 | 9 | SS | VELCADE | BORTEZOMIB | 1 | Unknown | U | 0 | UNKNOWN | |||||||||
| 125704303 | 12570430 | 10 | C | AZMACORT | TRIAMCINOLONE ACETONIDE | 1 | Unknown | 0 | UNKNOWN | BID | |||||||||
| 125704303 | 12570430 | 11 | C | AUGMENTIN | AMOXICILLINCLAVULANATE POTASSIUM | 1 | Unknown | 0 | UNKNOWN |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125704303 | 12570430 | 1 | Plasma cell myeloma |
| 125704303 | 12570430 | 9 | Product used for unknown indication |
| 125704303 | 12570430 | 10 | Dyspnoea |
| 125704303 | 12570430 | 11 | Urinary tract infection |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125704303 | 12570430 | HO |
| 125704303 | 12570430 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125704303 | 12570430 | Cardiac failure congestive | |
| 125704303 | 12570430 | General physical health deterioration | |
| 125704303 | 12570430 | Pneumonia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125704303 | 12570430 | 1 | 200908 | 0 | ||
| 125704303 | 12570430 | 2 | 200912 | 2009 | 0 | |
| 125704303 | 12570430 | 3 | 20100105 | 0 | ||
| 125704303 | 12570430 | 4 | 20101027 | 0 | ||
| 125704303 | 12570430 | 5 | 20110104 | 2011 | 0 | |
| 125704303 | 12570430 | 6 | 201206 | 2013 | 0 | |
| 125704303 | 12570430 | 7 | 201412 | 0 | ||
| 125704303 | 12570430 | 8 | 201606 | 0 | ||
| 125704303 | 12570430 | 10 | 20111019 | 0 |